Encompass Health Co. (NYSE:EHC) is Copeland Capital Management LLC's 3rd Largest Position

Copeland Capital Management LLC raised its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 1.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,284,550 shares of the company's stock after purchasing an additional 12,433 shares during the period. Encompass Health accounts for about 2.2% of Copeland Capital Management LLC's holdings, making the stock its 3rd biggest position. Copeland Capital Management LLC owned 1.28% of Encompass Health worth $124,139,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of Encompass Health by 4.7% during the fourth quarter. Vanguard Group Inc. now owns 9,997,034 shares of the company's stock worth $667,002,000 after purchasing an additional 450,081 shares in the last quarter. GAMMA Investing LLC lifted its stake in Encompass Health by 31.9% in the first quarter. GAMMA Investing LLC now owns 616 shares of the company's stock valued at $51,000 after buying an additional 149 shares during the last quarter. Gibson Capital LLC acquired a new stake in shares of Encompass Health in the first quarter valued at approximately $203,000. Oliver Luxxe Assets LLC grew its position in shares of Encompass Health by 0.8% during the first quarter. Oliver Luxxe Assets LLC now owns 41,582 shares of the company's stock worth $3,434,000 after acquiring an additional 348 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its holdings in shares of Encompass Health by 122.9% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 61,611 shares of the company's stock valued at $5,088,000 after acquiring an additional 33,973 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Insider Transactions at Encompass Health

In other news, CFO Douglas E. Coltharp sold 12,260 shares of the business's stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total value of $1,058,528.40. Following the completion of the transaction, the chief financial officer now directly owns 136,227 shares of the company's stock, valued at $11,761,839.18. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 2.10% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on EHC shares. UBS Group raised their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research report on Wednesday, September 25th. Leerink Partners began coverage on Encompass Health in a research note on Wednesday, July 10th. They set an "outperform" rating and a $100.00 price objective for the company. Truist Financial lifted their target price on Encompass Health from $104.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, October 14th. Stephens restated an "overweight" rating and set a $105.00 price target on shares of Encompass Health in a research note on Tuesday, August 6th. Finally, Leerink Partnrs upgraded shares of Encompass Health to a "strong-buy" rating in a research report on Wednesday, July 10th. Eight analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $104.67.

Encompass Health Price Performance

Shares of EHC stock traded down $0.32 during midday trading on Tuesday, reaching $95.43. 439,596 shares of the company traded hands, compared to its average volume of 625,811. The firm's 50 day simple moving average is $93.03 and its two-hundred day simple moving average is $87.95. The firm has a market cap of $9.61 billion, a PE ratio of 25.81, a price-to-earnings-growth ratio of 1.43 and a beta of 0.88. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.35 and a quick ratio of 1.35. Encompass Health Co. has a 1-year low of $57.55 and a 1-year high of $98.74.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Monday, August 5th. The company reported $1.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.10. The firm had revenue of $1.30 billion during the quarter, compared to analysts' expectations of $1.30 billion. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. Encompass Health's revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.95 earnings per share. On average, equities research analysts expect that Encompass Health Co. will post 4.18 EPS for the current fiscal year.

Encompass Health declared that its board has approved a stock buyback plan on Wednesday, July 24th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to purchase up to 5.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's management believes its stock is undervalued.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.71%. The ex-dividend date is Thursday, January 2nd. Encompass Health's dividend payout ratio (DPR) is presently 18.38%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.